19 February 2020
There have been reported cases in China of respiratory infections caused by a novel coronavirus (COVID-19), which is classified as an airborne high consequence infectious disease (HCID) in the UK. As of 17 February 2020, nine patients in England have tested positive for coronavirus. Governments and ...
12 February 2020
Dr Damian Roland explains why innovation is one of the four major workstreams we are considering in our Paediatrics 2040 project.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
4 February 2020
Professor Steve Turner shares an update on the data and evidence activity that’s underway to support our Paediatrics 2040 project.
3 February 2020
NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.
29 January 2020
Dr Nicola Jay reflects on her first six months as Officer for Workforce Planning and Health Services, and emphasises the importance of good data to her job.
9 January 2020
As a paediatrician, there are many reasons you should become a mentor… Not only is it an essential part of your career development, but the skills and experiences you will acquire along the way will be incredibly valuable to you and your career.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
25 October 2019
Next year’s RCPCH Conference will play host to a diverse line-up of prominent speakers who will take to the main stage over the three-day event.
16 October 2019
Withdrawal and Medicines Alerts for Ranitidine Related Products Zantac®, used to treat conditions such as acid reflux in children, has been recalled by its manufacturer because of concerns that it may contain low levels of NDMA.